Literature DB >> 17376686

A second pedigree with autosomal dominant nemaline myopathy caused by TPM3 mutation: a clinical and pathological study.

Isabelle Pénisson-Besnier1, Nicole Monnier, Annick Toutain, Frédéric Dubas, Nigel Laing.   

Abstract

The slow alpha-tropomyosin (TPM3) gene has to date been associated with few cases of both dominant and recessive nemaline myopathies. We report the identification of a p.Arg167His mutation in a four-generation family presenting with a mild classical form of the disease. Clinically, there was no correlation between the age at presentation and the severity of the disease. The dominant-negative p.Arg167His mutation is a recurrent mutation, previously reported in one sporadic case. Histological studies showed discrepancy between the two reports. While a type II fibre predominance was described in the sporadic case, we observed an almost complete type I fibre predominance. This study emphasizes the variability in histopathological phenotypes seen with TPM3 mutations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17376686     DOI: 10.1016/j.nmd.2007.01.017

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  12 in total

1.  Disrupted myosin cross-bridge cycling kinetics triggers muscle weakness in nebulin-related myopathy.

Authors:  Julien Ochala; Vilma-Lotta Lehtokari; Hiroyuki Iwamoto; Meishan Li; Han-Zhong Feng; Jian-Ping Jin; Naoto Yagi; Carina Wallgren-Pettersson; Isabelle Pénisson-Besnier; Lars Larsson
Journal:  FASEB J       Date:  2011-02-24       Impact factor: 5.191

2.  Mutations of tropomyosin 3 (TPM3) are common and associated with type 1 myofiber hypotrophy in congenital fiber type disproportion.

Authors:  Michael W Lawlor; Elizabeth T Dechene; Emily Roumm; Amelia S Geggel; Behzad Moghadaszadeh; Alan H Beggs
Journal:  Hum Mutat       Date:  2010-02       Impact factor: 4.878

3.  Myofilament lattice structure in presence of a skeletal myopathy-related tropomyosin mutation.

Authors:  Julien Ochala; Hiroyuki Iwamoto
Journal:  J Muscle Res Cell Motil       Date:  2013-05-18       Impact factor: 2.698

Review 4.  Thin filament proteins mutations associated with skeletal myopathies: defective regulation of muscle contraction.

Authors:  Julien Ochala
Journal:  J Mol Med (Berl)       Date:  2008-06-24       Impact factor: 4.599

5.  Defective regulation of contractile function in muscle fibres carrying an E41K beta-tropomyosin mutation.

Authors:  Julien Ochala; Meishan Li; Monica Ohlsson; Anders Oldfors; Lars Larsson
Journal:  J Physiol       Date:  2008-04-17       Impact factor: 5.182

6.  Disease severity and thin filament regulation in M9R TPM3 nemaline myopathy.

Authors:  Biljana Ilkovski; Nancy Mokbel; Raymond A Lewis; Kendall Walker; Kristen J Nowak; Ana Domazetovska; Nigel G Laing; Velia M Fowler; Kathryn N North; Sandra T Cooper
Journal:  J Neuropathol Exp Neurol       Date:  2008-09       Impact factor: 3.685

7.  Congenital myopathy-causing tropomyosin mutations induce thin filament dysfunction via distinct physiological mechanisms.

Authors:  Julien Ochala; David S Gokhin; Isabelle Pénisson-Besnier; Susana Quijano-Roy; Nicole Monnier; Joël Lunardi; Norma B Romero; Velia M Fowler
Journal:  Hum Mol Genet       Date:  2012-07-13       Impact factor: 6.150

8.  Expression profiles of muscle disease-associated genes and their isoforms during differentiation of cultured human skeletal muscle cells.

Authors:  Saba Abdul-Hussein; Peter F M van der Ven; Homa Tajsharghi
Journal:  BMC Musculoskelet Disord       Date:  2012-12-29       Impact factor: 2.362

9.  Muscle weakness in TPM3-myopathy is due to reduced Ca2+-sensitivity and impaired acto-myosin cross-bridge cycling in slow fibres.

Authors:  Michaela Yuen; Sandra T Cooper; Steve B Marston; Kristen J Nowak; Elyshia McNamara; Nancy Mokbel; Biljana Ilkovski; Gianina Ravenscroft; John Rendu; Josine M de Winter; Lars Klinge; Alan H Beggs; Kathryn N North; Coen A C Ottenheijm; Nigel F Clarke
Journal:  Hum Mol Genet       Date:  2015-08-24       Impact factor: 6.150

10.  Mutation update and genotype-phenotype correlations of novel and previously described mutations in TPM2 and TPM3 causing congenital myopathies.

Authors:  Minttu Marttila; Vilma-Lotta Lehtokari; Steven Marston; Tuula A Nyman; Christine Barnerias; Alan H Beggs; Enrico Bertini; Ozge Ceyhan-Birsoy; Pascal Cintas; Marion Gerard; Brigitte Gilbert-Dussardier; Jacob S Hogue; Cheryl Longman; Bruno Eymard; Moshe Frydman; Peter B Kang; Lars Klinge; Hanna Kolski; Hans Lochmüller; Laurent Magy; Véronique Manel; Michèle Mayer; Eugenio Mercuri; Kathryn N North; Sylviane Peudenier-Robert; Helena Pihko; Frank J Probst; Ricardo Reisin; Willie Stewart; Ana Lia Taratuto; Marianne de Visser; Ekkehard Wilichowski; John Winer; Kristen Nowak; Nigel G Laing; Tom L Winder; Nicole Monnier; Nigel F Clarke; Katarina Pelin; Mikaela Grönholm; Carina Wallgren-Pettersson
Journal:  Hum Mutat       Date:  2014-05-01       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.